Skip to main content
CNO
NYSE Finance

CNO Financial Details Strong 2025 Performance, High Executive Payouts, and Substantial Capital Returns

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
7
Price
$40.96
Mkt Cap
$3.862B
52W Low
$34.63
52W High
$44.855
Market data snapshot near publication time

summarizeSummary

CNO Financial Group's definitive proxy statement reveals robust 2025 operating performance, leading to significant executive compensation payouts tied to outperforming TSR and substantial capital returns to shareholders.


check_boxKey Events

  • Strong Executive Performance Payouts

    2023-2025 performance share awards paid out at 115.8% (Operating ROE) and 112.9% (Operating EPS) of target, after a 25% increase from a 90th percentile relative Total Shareholder Return.

  • Significant Capital Returns

    The company returned $386.1 million to shareholders in 2025, including $319.9 million in share repurchases, and has $420.4 million remaining authorization.

  • Positive Operational Results

    Despite a GAAP net income decrease due to non-economic factors, net operating income increased in 2025, alongside record sales growth in both Consumer and Worksite Divisions.

  • Routine Annual Meeting Proposals

    Shareholders will vote on the election of nine directors, an advisory vote on executive compensation, and the ratification of PricewaterhouseCoopers LLP as the independent auditor at the Annual Meeting on May 12, 2026.


auto_awesomeAnalysis

The DEF 14A filing highlights CNO Financial Group's robust operational and financial performance in 2025, which translated into above-target executive compensation. Notably, the 2023-2025 performance share awards paid out at over 110% of target, boosted by a 25% modifier due to the company's total shareholder return ranking in the 90th percentile against its peer group. The company also returned a substantial $386.1 million to shareholders in 2025, including $319.9 million in share repurchases, demonstrating a commitment to shareholder value. While GAAP net income decreased due to non-economic accounting impacts and an impairment charge, net operating income increased, providing important context for investors.

At the time of this filing, CNO was trading at $40.96 on NYSE in the Finance sector, with a market capitalization of approximately $3.9B. The 52-week trading range was $34.63 to $44.86. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CNO - Latest Insights

CNO
Mar 26, 2026, 4:13 PM EDT
Filing Type: DEF 14A
Importance Score:
7
CNO
Feb 24, 2026, 4:54 PM EST
Filing Type: 10-K
Importance Score:
7
CNO
Feb 05, 2026, 4:16 PM EST
Filing Type: 8-K
Importance Score:
8